The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
D000328:Adult; D000535:Aluminum / Q000009:adverse effects* / Q000097:blood; D002119:Calcium Carbonate / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology* / Q000378:metabolism; D003676:Deferoxamine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010018:Osteomalacia / Q000139:chemically induced / Q000188:drug therapy; D010281:Parathyroid Hormone / Q000097:blood*; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*
D010281:Parathyroid Hormone; D010710:Phosphates; D000535:Aluminum; D002119:Calcium Carbonate; D003676:Deferoxamine